If momentum is unwinding, or at least taking a pause, it makes sense that some of the sharemarket’s most influential trades ...

Cautious investors dragged the Australian sharemarket and dollar lower as they await the fallout from US President Donald ...

Why would I sell one of my longest-held stocks? The post I sold one of my oldest ASX 200 shares last week. Here's why ...

Let's see what brokers are saying about these buy-rated top stocks. The post These ASX 200 shares could rise 15% to 30% ...

With Wall Street closed for the Independence Day holiday, investors are looking ahead to the big events of the week — the RBA rates decision and the end of the 90-day US tariff pause.

ASX 200 tech shares delivered another exceptional performance for investors in FY25 with a return of 24%. Experts rate these ...

Welcome to the Trading Day blog for Monday, July 7. The ASX 200 index fell 0.2 per cent to 8589,3 points on Monday, as ...

The S&P/ASX 200 Index is set to rise 0.1 per cent with markets largely pricing in major decisions. Still, strategists say ...

The ASX 200 has zig-zagged as investors brace for Donald Trump’s 90-day tariff pause to end this week and await another cut ...

This ASX 300 healthcare stock is starting the week in a positive fashion. Let's see why its shares are charging ...

That rule of thumb was triggered recently. On June 20, the ASX 200 formed a Golden Cross. Just days later, on July 1, the S&P ...

Why it matters: Pro Medicus is accruing contracted revenue slightly faster than our expectations in the key existing academic ...